# Pharmacogenetics of Doxazosin for Cocaine Dependence

> **NCT01145183** · PHASE2 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 96 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Doxazosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01145183
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2019-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01145183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01145183, "Pharmacogenetics of Doxazosin for Cocaine Dependence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01145183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*